The Oxford University COVID-19 vaccine undergoing Phase III clinical trials with British pharma giant AstraZeneca is doing 'everything expected' which means good news in the fight against the......
A 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and......
Vital health parameters of the two volunteers, who have been administered the Oxford COVID-19 vaccine candidate at a medical college in Pune as part of the phase II clinical trial, are normal, a......
United States President Donald Trump on Sunday (local time) expressed confidence that a vaccine for coronavirus could be available by the end of the year. "I think we'll have a vaccine by the end......